RxDoctor Payments Data
★ My doctorsLook up a doctor →

Joseph Marshalek

Torrance, CANPI 1477180016

Payments from drug & device makers

$1,828in general payments, 2019–2025

Across 61 payments — averaging $29.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$260
  • E.r. Squibb & Sons, L.L.C.$235
  • AstraZeneca$165
  • Astellas Pharma US Inc$133
  • Lilly USA, LLC$90
  • EMD Serono, Inc.$89
  • plus $856 from 21 others

What the payments were for

  • Food & beverage$1,53884%
  • Education$29016%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson6$260
E.r. Squibb & Sons, L.L.C.13$235
AstraZeneca6$165
Astellas Pharma US Inc2$133
Lilly USA, LLC1$90
EMD Serono, Inc.2$89
Daiichi Sankyo Inc.3$80
Beone Medicines USA, Inc.2$63
Bristol Myers Squibb2$61
ADC Therapeutics America, Inc.2$61
Sanofi2$57
Springworks Therapeutics, Inc.2$56
Incyte Corporation2$54
Exelixis Inc.2$51
AbbVie2$50
Agios Pharmaceuticals, Inc.1$39
Genentech USA, Inc.1$34
Jazz Pharmaceuticals Inc.1$31
Pharmaessentia USA Corporation1$31
Beigene USA, Inc.1$29
Aurinia Pharma U.S., Inc.1$27
Deciphera Pharmaceuticals Inc.1$26
Geron Corporation1$24
Blueprint Medicines Corporation1$23
Kyowa Kirin, Inc.1$21
Pfizer1$20
Mirati Therapeutics, Inc.1$20

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisone15$66
Oxycodone Hcl12$61

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →